Healthcare investment firm venBio Partners LLC raised $288 million from 22 LPs toward a $303 million venture fund, according to an SEC filing.
The target on venBio Global Strategic Fund II LP was increased from a March 2015 filing, which set a goal of $250 million for the fund.
VenBio, which has offices in San Francisco and New York, typically invests in clinical-stage life science companies with a therapeutic product. In addition to venture capital funds, the firm manages a long-short equity hedge fund.DON'T MISS IT! Now in its 10th year, PartnerConnect Midwest is bringing you 300 attendees, over 400 private ExecConnect meetings between LPs and GPs, and three insightful tracks including Buyouts Funds, Buyouts Deals and Co-Investments. REGISTER TODAY!